5 Stocks Pushing The Health Care Sector Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 30 points (-0.2%) at 14,005 as of Wednesday, Feb. 20, 2013, 12:04 PM ET. The NYSE advances/declines ratio sits at 991 issues advancing vs. 1,875 declining with 138 unchanged.

The Health Care sector currently sits down 0.1% versus the S&P 500, which is down 0.5%. On the negative front, top decliners within the sector include Life Technologies ( LIFE), down 7.4%, Thermo Fisher Scientific ( TMO), down 2.5%, Medtronic ( MDT), down 2.2%, UnitedHealth Group ( UNH), down 1.8% and Cigna ( CI), down 1.0%. Top gainers within the sector include Pharmacyclics Incorporated ( PCYC), up 2.4%, Express Scripts ( ESRX), up 1.9%, Alexion Pharmaceuticals ( ALXN), up 1.4%, Amgen ( AMGN), up 1.1% and Teva Pharmaceutical Industries ( TEVA), up 0.7%.

TheStreet Ratings group would like to highlight 5 stocks pushing the sector lower today:

5. Boston Scientific ( BSX) is one of the companies pushing the Health Care sector lower today. As of noon trading, Boston Scientific is down $0.14 (-1.9%) to $7.36 on average volume Thus far, 8.5 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 20.7 million shares. The stock has ranged in price between $7.34-$7.54 after having opened the day at $7.48 as compared to the previous trading day's close of $7.50.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $10.4 billion and is part of the health services industry. The company has a P/E ratio of 11.4, below the S&P 500 P/E ratio of 17.7. Shares are up 31.6% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 15 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Boston Scientific Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

4. As of noon trading, HCA Holdings ( HCA) is down $0.79 (-2.2%) to $35.62 on light volume Thus far, 1.3 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 4.3 million shares. The stock has ranged in price between $35.59-$36.36 after having opened the day at $36.32 as compared to the previous trading day's close of $36.41.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $16.0 billion and is part of the health services industry. The company has a P/E ratio of 9.8, below the S&P 500 P/E ratio of 17.7. Shares are up 20.3% year to date as of the close of trading on Tuesday. Currently there are 18 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, weak operating cash flow and poor profit margins. Get the full HCA Holdings Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

3. As of noon trading, Aetna ( AET) is down $0.62 (-1.3%) to $48.10 on light volume Thus far, 1.1 million shares of Aetna exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $48.04-$48.82 after having opened the day at $48.73 as compared to the previous trading day's close of $48.71.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $16.5 billion and is part of the health services industry. The company has a P/E ratio of 9.6, below the S&P 500 P/E ratio of 17.7. Shares are up 6.2% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Aetna Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

2. As of noon trading, Baxter International ( BAX) is down $0.42 (-0.6%) to $67.90 on light volume Thus far, 615,545 shares of Baxter International exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $67.85-$68.25 after having opened the day at $68.20 as compared to the previous trading day's close of $68.32.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.4 billion and is part of the health services industry. The company has a P/E ratio of 15.0, below the S&P 500 P/E ratio of 17.7. Shares are up 2.3% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Baxter International Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

1. As of noon trading, Intuitive Surgical ( ISRG) is down $17.13 (-2.9%) to $565.14 on average volume Thus far, 242,592 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 415,800 shares. The stock has ranged in price between $564.12-$577.69 after having opened the day at $576.01 as compared to the previous trading day's close of $582.27.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $22.8 billion and is part of the health services industry. The company has a P/E ratio of 35.6, above the S&P 500 P/E ratio of 17.7. Shares are up 16.1% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Intuitive Surgical Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null